Quick Answer
BridgeBio Pharma, Inc. reported Earnings Per Share Diluted of $3.78 (loss) per share for the year ending 2025.
- BridgeBio Pharma, Inc. showed a decrease of -31.3% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from BridgeBio Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), BridgeBio Pharma, Inc.'s Earnings Per Share Diluted has grown by 0.5%.
- Historical annual values: Fiscal year 2025: $3.78 (loss) per share | Fiscal year 2024: $2.88 (loss) per share | Fiscal year 2023: $3.95 (loss) per share | Fiscal year 2022: $3.26 (loss) per share | Fiscal year 2021: $3.90 (loss) per share | Fiscal year 2020: $3.80 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: